Copyright Reports & Markets. All rights reserved.

Global Peramivir Intermediate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Peramivir Intermediate Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Medicine Grade
    • 1.3.3 Chemical Grade
  • 1.4 Market Analysis by Synthesis Stage
    • 1.4.1 Overview: Global Peramivir Intermediate Consumption Value by Synthesis Stage: 2021 Versus 2025 Versus 2032
    • 1.4.2 Early Stage
    • 1.4.3 Middle Stage
    • 1.4.4 Late Stage
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Peramivir Intermediate Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Pharmaceuticals
    • 1.5.3 Scientific Research
    • 1.5.4 Other
  • 1.6 Global Peramivir Intermediate Market Size & Forecast
    • 1.6.1 Global Peramivir Intermediate Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Peramivir Intermediate Sales Quantity (2021-2032)
    • 1.6.3 Global Peramivir Intermediate Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 PharmaResources
    • 2.1.1 PharmaResources Details
    • 2.1.2 PharmaResources Major Business
    • 2.1.3 PharmaResources Peramivir Intermediate Product and Services
    • 2.1.4 PharmaResources Peramivir Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 PharmaResources Recent Developments/Updates
  • 2.2 Jinan Jianfeng Chemical
    • 2.2.1 Jinan Jianfeng Chemical Details
    • 2.2.2 Jinan Jianfeng Chemical Major Business
    • 2.2.3 Jinan Jianfeng Chemical Peramivir Intermediate Product and Services
    • 2.2.4 Jinan Jianfeng Chemical Peramivir Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Jinan Jianfeng Chemical Recent Developments/Updates
  • 2.3 Shandong Kelikang Pharmaceutical
    • 2.3.1 Shandong Kelikang Pharmaceutical Details
    • 2.3.2 Shandong Kelikang Pharmaceutical Major Business
    • 2.3.3 Shandong Kelikang Pharmaceutical Peramivir Intermediate Product and Services
    • 2.3.4 Shandong Kelikang Pharmaceutical Peramivir Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shandong Kelikang Pharmaceutical Recent Developments/Updates
  • 2.4 Jiangsu Zenji Pharmaceuticals
    • 2.4.1 Jiangsu Zenji Pharmaceuticals Details
    • 2.4.2 Jiangsu Zenji Pharmaceuticals Major Business
    • 2.4.3 Jiangsu Zenji Pharmaceuticals Peramivir Intermediate Product and Services
    • 2.4.4 Jiangsu Zenji Pharmaceuticals Peramivir Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Jiangsu Zenji Pharmaceuticals Recent Developments/Updates
  • 2.5 Jinan Gongchuang Pharmaceutical Technology
    • 2.5.1 Jinan Gongchuang Pharmaceutical Technology Details
    • 2.5.2 Jinan Gongchuang Pharmaceutical Technology Major Business
    • 2.5.3 Jinan Gongchuang Pharmaceutical Technology Peramivir Intermediate Product and Services
    • 2.5.4 Jinan Gongchuang Pharmaceutical Technology Peramivir Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Jinan Gongchuang Pharmaceutical Technology Recent Developments/Updates
  • 2.6 Ruifu Chemical
    • 2.6.1 Ruifu Chemical Details
    • 2.6.2 Ruifu Chemical Major Business
    • 2.6.3 Ruifu Chemical Peramivir Intermediate Product and Services
    • 2.6.4 Ruifu Chemical Peramivir Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ruifu Chemical Recent Developments/Updates

3 Competitive Environment: Peramivir Intermediate by Manufacturer

  • 3.1 Global Peramivir Intermediate Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Peramivir Intermediate Revenue by Manufacturer (2021-2026)
  • 3.3 Global Peramivir Intermediate Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Peramivir Intermediate by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Peramivir Intermediate Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Peramivir Intermediate Manufacturer Market Share in 2025
  • 3.5 Peramivir Intermediate Market: Overall Company Footprint Analysis
    • 3.5.1 Peramivir Intermediate Market: Region Footprint
    • 3.5.2 Peramivir Intermediate Market: Company Product Type Footprint
    • 3.5.3 Peramivir Intermediate Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Peramivir Intermediate Market Size by Region
    • 4.1.1 Global Peramivir Intermediate Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Peramivir Intermediate Consumption Value by Region (2021-2032)
    • 4.1.3 Global Peramivir Intermediate Average Price by Region (2021-2032)
  • 4.2 North America Peramivir Intermediate Consumption Value (2021-2032)
  • 4.3 Europe Peramivir Intermediate Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Peramivir Intermediate Consumption Value (2021-2032)
  • 4.5 South America Peramivir Intermediate Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Peramivir Intermediate Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Peramivir Intermediate Sales Quantity by Type (2021-2032)
  • 5.2 Global Peramivir Intermediate Consumption Value by Type (2021-2032)
  • 5.3 Global Peramivir Intermediate Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Peramivir Intermediate Sales Quantity by Application (2021-2032)
  • 6.2 Global Peramivir Intermediate Consumption Value by Application (2021-2032)
  • 6.3 Global Peramivir Intermediate Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Peramivir Intermediate Sales Quantity by Type (2021-2032)
  • 7.2 North America Peramivir Intermediate Sales Quantity by Application (2021-2032)
  • 7.3 North America Peramivir Intermediate Market Size by Country
    • 7.3.1 North America Peramivir Intermediate Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Peramivir Intermediate Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Peramivir Intermediate Sales Quantity by Type (2021-2032)
  • 8.2 Europe Peramivir Intermediate Sales Quantity by Application (2021-2032)
  • 8.3 Europe Peramivir Intermediate Market Size by Country
    • 8.3.1 Europe Peramivir Intermediate Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Peramivir Intermediate Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Peramivir Intermediate Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Peramivir Intermediate Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Peramivir Intermediate Market Size by Region
    • 9.3.1 Asia-Pacific Peramivir Intermediate Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Peramivir Intermediate Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Peramivir Intermediate Sales Quantity by Type (2021-2032)
  • 10.2 South America Peramivir Intermediate Sales Quantity by Application (2021-2032)
  • 10.3 South America Peramivir Intermediate Market Size by Country
    • 10.3.1 South America Peramivir Intermediate Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Peramivir Intermediate Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Peramivir Intermediate Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Peramivir Intermediate Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Peramivir Intermediate Market Size by Country
    • 11.3.1 Middle East & Africa Peramivir Intermediate Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Peramivir Intermediate Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Peramivir Intermediate Market Drivers
  • 12.2 Peramivir Intermediate Market Restraints
  • 12.3 Peramivir Intermediate Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Peramivir Intermediate and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Peramivir Intermediate
  • 13.3 Peramivir Intermediate Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Peramivir Intermediate Typical Distributors
  • 14.3 Peramivir Intermediate Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Peramivir Intermediate market size was valued at US$ 7.17 million in 2025 and is forecast to a readjusted size of US$ 11.26 million by 2032 with a CAGR of 6.6% during review period.
    In 2025, based on a combined calculation of multiple route intermediates, the global sales volume of Peramivir Intermediate was approximately 45 tons, with an average global market price of about USD 155/kg. The gross margin of major producers in the industry was approximately 30%-50%.
    Peramivir Intermediate refers to a group of specialized organic synthesis intermediates formed around the construction of the peramivir molecular skeleton. It is not a single fixed compound, but includes multiple route intermediates with different structures and CAS numbers. These products generally feature structural characteristics such as chiral cyclopentane, cyclopentene, isoxazole, Boc-protected amino groups, carboxylate esters, and hydroxy amino groups. Their synthesis typically involves chiral control, introduction and removal of protecting groups, functional group transformation, selective reduction, esterification, or hydrolysis. Due to structural differences among intermediates at different route stages, their appearance, purity, impurity profile, stability, and storage conditions may vary.
    The upstream industry chain of Peramivir Intermediate mainly includes chiral cyclopentene/cyclopentane raw materials, guanidination reagents, Boc protection reagents, carboxylate esterification reagents, solvents, catalysts, reducing agents, and acid-base reagents. Downstream, it is mainly used to produce peramivir API, which can be further processed into peramivir trihydrate or finished dosage forms such as peramivir injection.
    This report is a detailed and comprehensive analysis for global Peramivir Intermediate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Peramivir Intermediate market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
    Global Peramivir Intermediate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
    Global Peramivir Intermediate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
    Global Peramivir Intermediate market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Peramivir Intermediate
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Peramivir Intermediate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PharmaResources, Jinan Jianfeng Chemical, Shandong Kelikang Pharmaceutical, Jiangsu Zenji Pharmaceuticals, Jinan Gongchuang Pharmaceutical Technology, Ruifu Chemical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Peramivir Intermediate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Medicine Grade
    Chemical Grade
    Market segment by Synthesis Stage
    Early Stage
    Middle Stage
    Late Stage
    Market segment by Application
    Pharmaceuticals
    Scientific Research
    Other
    Major players covered
    PharmaResources
    Jinan Jianfeng Chemical
    Shandong Kelikang Pharmaceutical
    Jiangsu Zenji Pharmaceuticals
    Jinan Gongchuang Pharmaceutical Technology
    Ruifu Chemical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Peramivir Intermediate product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Peramivir Intermediate, with price, sales quantity, revenue, and global market share of Peramivir Intermediate from 2021 to 2026.
    Chapter 3, the Peramivir Intermediate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Peramivir Intermediate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Peramivir Intermediate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Peramivir Intermediate.
    Chapter 14 and 15, to describe Peramivir Intermediate sales channel, distributors, customers, research findings and conclusion.

    Buy now